HLA B57:01 Molecular Detection Epic Compendium
▶ Desired Epic Build
* = editable field
Actual Epic Build 12/05/2025
| PROCEDURE ID | 115147 | ||||||||||||
| PDM | 228468 | ||||||||||||
| ORDER DISPLAY NAME | HLA B57:01 Molecular Detection | ||||||||||||
| PROCEDURE NAME | HLX HLA B57-1 ANTIGEN CASE | ||||||||||||
| PROCEDURE MASTER NUMBER | LAB11403 | ||||||||||||
| SHORT PROCEDURE NAME | HLX HLA B57-1 ANTIGEN CASE | ||||||||||||
| CATEGORY CODE | 21.0 | ||||||||||||
| CATEGORY CODE RECORD NAME | LAB MOLECULAR DIAGNOSTICS ORDERABLES | ||||||||||||
| SYNONYMS | ABACAVIR SENSITIVITY HLAB5701 HLA-B 5701 GENOTYPE HLA ANTIGEN B5701 ABACAVIR HYPERSENSITIVITY GENOTYPING |
||||||||||||
| CLINICALLY ACTIVE | Yes | ||||||||||||
| ORDERABLE | Yes | ||||||||||||
| PERFORMABLE | Yes | ||||||||||||
| FILTER GENOMICS | Generic Genomics Procedure | ||||||||||||
| REFERENCE LINK URL | https://labs.northwell.edu/epic/test/115147 | ||||||||||||
| ORDERING INSTRUCTIONS | Hypersensitivity to abacavir has been strongly associated with the HLA-B*57:01 allele. DNA-based testing to assess the presence of HLA-B*57:01 offers higher specificity than serologic testing because monoclonal antibodies may show cross-reactivity with other HLA subtypes. The U.S. Food and Drug Administration (FDA) recommends pre-therapeutic screening for the HLA-B*57:01 allele. Routine screening has been shown to reduce the incidence of ABC HSR from 8% to <0.5% in abacavir-navØve patients. Patients testing positive should not be treated with a regimen containing abacavir. |
||||||||||||
| DEFAULT SPECIMEN TYPE | Blood | ||||||||||||
| SPECIMEN TYPE PICK LIST | Blood | ||||||||||||
| SPECIMEN TYPE LIST | |||||||||||||
| OP SPECIMEN TYPE LIST | |||||||||||||
| SPECIMEN SOURCE PICK LIST | Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous |
||||||||||||
| SPECIMEN SOURCE DEFAULT - MALE | Blood, Venous | ||||||||||||
| SPECIMEN SOURCE DEFAULT - FEMALE | Blood, Venous | ||||||||||||
| SPECIMEN SOURCE LIST | |||||||||||||
| OP SPECIMEN SOURCE LIST | |||||||||||||
| IP LAB TEST COMPONENTS FOR REPORT | HLXB57501 | ||||||||||||
| OP LAB TEST COMPONENTS FOR REPORT | HLXB57501 | ||||||||||||
| ORDER QUESTIONS | ["3046700000"] | ||||||||||||
| ORDER QUESTIONS RECORD NAME | NH IP LAB PATIENT CONSENT? | ||||||||||||
| INPATIENT ORDER QUESTIONS | ["3046700000"] | ||||||||||||
| INPATIENT ORDER QUESTIONS RECORD NAME | NH IP LAB PATIENT CONSENT? | ||||||||||||
| ORDER SPECIFIC QUESTION OVERRIDE | Yes | ||||||||||||
| INPATIENT QUESTION OVERRIDE | Yes | ||||||||||||
| LOCATION RESTRICT LIST IP | |||||||||||||
| LOCATION RESTRICT LIST IP RECORD NAME | |||||||||||||
| LOCATION RESTRICT LIST INCLUDE IP | |||||||||||||
| LOCATION RESTRICT LIST OP | |||||||||||||
| LOCATION RESTRICT LIST OP RECORD NAME | |||||||||||||
| LOCATION RESTRICT LIST INCLUDES OP | |||||||||||||
| EDP AMB ORDER SPECIFIC QUESTIONS RECORD NAME | NH IP PATIENT COMPLETED CONSENT | ||||||||||||
| EDP IP ORDER SPECIFIC QUESTIONS RECORD NAME | NH IP PATIENT COMPLETED CONSENT | ||||||||||||
| EDP IP SPECIMEN SOURCE | |||||||||||||
| EDP OP SPECIMEN SOURCE | |||||||||||||
| EDP IP SPECIMEN TYPE | |||||||||||||
| EDP OP SPECIMEN TYPE | |||||||||||||
| DERIVED EDP IP BUTTONS S | |||||||||||||
| DERIVED EDP IP BUTTONS T | |||||||||||||
| DERIVED EDP OP BUTTONS S | |||||||||||||
| DERIVED EDP OP BUTTONS T | |||||||||||||
| IP ORDERABLE | 1 | ||||||||||||
| OP ORDERABLE | 1 | ||||||||||||
| STANDARD LAB COMPONENTS | |||||||||||||
| STANDARD LAB COMPONENTS RECORD NAME | |||||||||||||
| COMPONENT DATA REQUIREMENT | |||||||||||||
EPIC OP AOEs
| |||||||||||||
EPIC IP AOEs
| |||||||||||||
| EPIC Components (results - crosswalked through Cerner) | |||||||||||||